Search results for "TRIGLYCERIDES"

showing 10 items of 301 documents

Lipid profile, cardiovascular disease and mortality in a Mediterranean high-risk population: The ESCARVAL-RISK study

2018

Introduction The potential impact of targeting different components of an adverse lipid profile in populations with multiple cardiovascular risk factors is not completely clear. This study aims to assess the association between different components of the standard lipid profile with all-cause mortality and hospitalization due to cardiovascular events in a high-risk population. Methods This prospective registry included high risk adults over 30 years old free of cardiovascular disease (2008–2012). Diagnosis of hypertension, dyslipidemia or diabetes mellitus was inclusion criterion. Lipid biomarkers were evaluated. Primary endpoints were all-cause mortality and hospital admission due to coron…

AdultMaleDeath RatesEndocrine Disorderslcsh:MedicineBlood PressureCoronary DiseaseCardiovascular Medicine030204 cardiovascular system & hematologyBiochemistryVascular Medicine03 medical and health sciencesEndocrinology0302 clinical medicinePopulation MetricsRisk FactorsMalalties ComplicacionsMortalitatMedicine and Health SciencesDiabetes MellitusHumans030212 general & internal medicinelcsh:ScienceTriglyceridesSistema cardiovascularAgedMultidisciplinaryPopulation BiologyCholesterol HDLlcsh:RBiology and Life SciencesCorrectionCholesterol LDLMiddle AgedLipidsHospitalizationStrokeCholesterolNephrologyCardiovascular DiseasesMetabolic DisordersHypertensionlipids (amino acids peptides and proteins)Femalelcsh:QBiomarkersResearch ArticlePLOS ONE
researchProduct

Oxidative status in nondiabetic middle-aged subjects with metabolic syndrome: preliminary data.

2013

AdultMaleEndocrinology Diabetes and MetabolismMedicine (miscellaneous)PhysiologyEnzyme-Linked Immunosorbent AssayOxidative phosphorylationNitric OxideAntioxidantsProtein CarbonylationText miningMedicineHumansTriglyceridesMetabolic SyndromeNutrition and Dieteticsbusiness.industryCholesterol HDLMiddle Agedmedicine.diseaseOxidative StressLinear ModelsFemaleLipid PeroxidationMetabolic syndromeCardiology and Cardiovascular MedicinebusinessLipid peroxidation total antioxidant status insulin resistanceNutrition, metabolism, and cardiovascular diseases : NMCD
researchProduct

Gemfibrozil reduces small low-density lipoprotein more in normolipemic subjects classified as low-density lipoprotein pattern B compared with pattern…

2005

We tested the hypothesis that gemfibrozil has a differential effect on low-density lipoprotein (LDL) and high-density lipoprotein (HDL) subclass distributions and postprandial lipemia that is different in subjects classified as having LDL subclass pattern A or LDL pattern B who do not have a classic lipid disorder. Forty-three normolipemic subjects were randomized to gemfibrozil (1,200 mg/day) or placebo for 12 weeks. Lipids and lipoproteins were determined by enzymatic methods. The mass concentrations of lipoproteins in plasma were determined by analytic ultracentrifugation and included the S(f) intervals: 20 to 400 (very LDL), 12 to 20 (intermediate-density lipoprotein), 0 to 12 (LDL), an…

AdultMaleHyperlipoproteinemiasmedicine.medical_specialtySmall dense ldlLipid disorderApolipoprotein BLipoproteins VLDLPlacebochemistry.chemical_compoundDouble-Blind MethodInternal medicinemedicineHumansGemfibrozilTriglyceridesAgedHypolipidemic Agentsbiologybusiness.industryMiddle AgedPostprandial PeriodLipoproteins LDLTreatment OutcomeEndocrinologyPostprandialchemistryLow-density lipoproteinbiology.proteinFemalelipids (amino acids peptides and proteins)GemfibrozilLipoproteins HDLCardiology and Cardiovascular MedicinebusinessGemfibrozil small low-density lipoprotein pattern B pattern ABiomarkersLipoproteinmedicine.drug
researchProduct

Associations of Birth Weight and Postnatal Weight Gain With Cardiometabolic Risk Parameters at 5 Years of Age

2014

The present prospective study assessed the impact of birth weight (BW) and postnatal weight gain on blood pressure and metabolic profile during the first 5 years of life. One hundred thirty-nine newborns (63 women) born at term after uncomplicated pregnancies and in the absence of perinatal illness were included. Subjects were divided according to size at birth in small, appropriate, and large for gestational age. After the initial evaluation on the second day of life, infants were followed up at 6 months and 2 and 5 years. Anthropometric parameters and blood pressure were measured at each visit and metabolic assessment was performed at 5 years of age. Among the BW groups, mothers did not d…

AdultMalePediatricsmedicine.medical_specialtyBirth weightPhysiologyHemodynamicsBlood PressureGestational AgeWeight GainBody Mass Indexchemistry.chemical_compoundRisk FactorsInternal MedicinemedicineBirth WeightHumansInsulinMetabolomicsProspective StudiesProspective cohort studyTriglyceridesPregnancybusiness.industryInfant NewbornInfantGestational ageCholesterol LDLmedicine.diseaseUric AcidBlood pressurechemistryChild PreschoolLinear ModelsUric acidFemalemedicine.symptombusinessWeight gainFollow-Up StudiesHypertension
researchProduct

Novel LMF1 nonsense mutation in a patient with severe hypertriglyceridemia

2009

Context: Lipase maturation factor 1 (LMF1) gene is a novel candidate gene in severe hypertriglyceridemia. Lmf1 is involved in the maturation of lipoprotein lipase (LPL) and hepatic lipase in endoplasmic reticulum. To date only one patient with severe hypertriglyceridemia and related disorders was found to be homozygous for a nonsense mutation in LMF1 gene (Y439X).Objective: The objective of the study was to investigate LMF1 gene in hypertriglyceridemic patients in whom mutations in LPL, APOC2, and APOA5 genes had been excluded.Results: The resequencing of LMF1 gene led to the discovery of a novel homozygous nonsense mutation in one patient with severe hypertriglyceridemia and recurrent epis…

AdultMaleProbandmedicine.medical_specialtyCandidate geneEndocrinology Diabetes and MetabolismMolecular Sequence DataClinical BiochemistryNonsense mutationContext (language use)macromolecular substances030204 cardiovascular system & hematologyBiologyBiochemistry03 medical and health sciencesExon0302 clinical medicineEndocrinologyInternal medicinemedicineHumansTriglyceridesHypolipidemic Agents030304 developmental biologyHypertriglyceridemia0303 health sciencesLipoprotein lipaseBase Sequencedigestive oral and skin physiologyBiochemistry (medical)Hypertriglyceridemianutritional and metabolic diseasesGenetic VariationLMF1 gene; nonsense mutation; hypertriglyceridemiaLMF1 hypertriglyceridemiamedicine.disease3. Good healthLipoprotein LipaseEndocrinologyCodon NonsenseOriginal Articlelipids (amino acids peptides and proteins)Hepatic lipaseGemfibrozil
researchProduct

Familial hypobetalipoproteinemia due to apolipoprotein B R463W mutation causes intestinal fat accumulation and low postprandial lipemia

2008

Abstract Objective Familial hypobetalipoproteinemia (FHBL) is characterized by inherited low plasma levels of apolipoprotein B (apoB)-containing lipoproteins. In this paper we investigated whether the already described APOB R463W missense mutation, a FHBL mutation able to impair the activity of microsomal triglyceride transfer protein (MTP), may cause intestinal fat accumulation and reduced postprandial lipemia. Methods Four out of five probands harboring APOB R463W mutation were compared with six healthy controls and six patients with celiac disease (CD). An oral fat load supplemented with retinyl palmitate (RP) was administered and a gastro-duodenal endoscopy with biopsy was performed. Re…

AdultMaleRetinyl Estersmedicine.medical_specialtySettore MED/09 - Medicina InternaAdolescentApolipoprotein BMutation MissenseapolipoproteinBlood lipidsHyperlipidemiasIntra-Abdominal FatBiologyMicrosomal triglyceride transfer proteinchemistry.chemical_compoundRetinyl palmitateInternal medicinemedicineHumansMissense mutationIntestinal MucosaChildVitamin ATriglyceridesApolipoproteins BTriglycerideMiddle AgedLipid MetabolismPostprandial Periodmedicine.diseasePostprandialEndocrinologychemistryHypobetalipoproteinemia Familial Apolipoprotein BB R463Wbiology.proteinFemalelipids (amino acids peptides and proteins)HypobetalipoproteinemiaDiterpenesCarrier ProteinsCardiology and Cardiovascular MedicineAtherosclerosis
researchProduct

Influence of the APOA5 locus on plasma triglyceride, lipoprotein subclasses, and CVD risk in the Framingham Heart Study

2004

Several polymorphisms in the APOA5 gene have been associated with increased plasma triglyceride (TG) concentrations. However, associations between APOA5 and lipoprotein subclasses, remnant-like particles (RLPs), and cardiovascular disease (CVD) risk have been less explored. We investigated associations of five APOA5 single-nucleotide polymorphisms (SNPs; −1131T>C, −3A>G, 56C>G IVS3+ 476G>A, and 1259T>C) with lipoprotein subfractions and CVD risk in 1,129 men and 1,262 women participating in the Framingham Heart Study. Except for the 56C>G SNP, the other SNPs were in significant linkage disequilibria, resulting in three haplotypes (11111, 22122, and 11211) representing 98% of the population.…

AdultMaleRiskhaplotypemedicine.medical_specialtyGenotypeLipoproteinsPopulationCoronary DiseaseSingle-nucleotide polymorphismQD415-436BiologyCardiovascular SystemPolymorphism Single NucleotideBiochemistryLinkage Disequilibriumchemistry.chemical_compoundSex FactorsEndocrinologyFramingham Heart StudyInternal medicineremnant-like particlesmedicineHumansSNPAlleleeducationAllelesApolipoproteins ATriglyceridesAgededucation.field_of_studyPolymorphism GeneticCholesterolHaplotypeGenetic VariationCell BiologyMiddle Agedcardiovascular disease riskApolipoproteinsCholesterolEndocrinologyHaplotypeschemistryApolipoprotein A-VCardiovascular DiseasesFemaleLipoproteinJournal of Lipid Research
researchProduct

Diabetes and coronary risk factors. Relative risk for single factors and aggregation of more factors in a general population sample from northern Ita…

1990

In the course of a general population survey in Mirano (Venice), Northern Italy, a random sample of 1,903 subjects (50.1% men) aged 20-59 was examined. Fifty-five were diabetic (fasting plasma glucose greater than or equal to 140 mg/dl or diagnosed by a physician) and 1,670 non-diabetic subjects (fasting plasma glucose below 110 mg/dl). In this paper an assessment was made on the more frequent occurrence of coronary risk factors (serum cholesterol and triglycerides, body mass index (BMI), systolic blood pressure, cigarette smoking) and, in particular, of their aggregation in diabetic patients as compared to non-diabetic controls. The occurrence of any one of the coronary risk factors studie…

AdultMaleRural Populationmedicine.medical_specialtyEndocrinology Diabetes and MetabolismBlood PressureCoronary DiseaseBody Mass IndexDiabetes Complicationschemistry.chemical_compoundSex FactorsEndocrinologyRisk FactorsDiabetes mellitusInternal medicineEpidemiologyInternal MedicinemedicineHumansTriglyceridesCholesterolbusiness.industrySmokingAge FactorsCoronary risk factorsGeneral MedicineMiddle Agedmedicine.diseaseNorthern italyCholesterolBlood pressureEndocrinologyItalychemistryRelative riskFemalebusinessBody mass indexActa Diabetologica Latina
researchProduct

Extreme duration exercise affects old and younger men differently.

2022

Aim & Methods: Extreme endurance exercise provides a valuable research model for understanding the adaptive metabolic response of older and younger individuals to intense physical activity. Here, we compare a wide range of metabolic and physiologic parameters in two cohorts of seven trained men, age 30 ± 5 years or age 65 ± 6 years, before and after the participants travelled ≈3000 km by bicycle over 15 days. Results: Over the 15-day exercise intervention, participants lost 2–3 kg fat mass with no significant change in body weight. V̇O2max did not change in younger cyclists, but decreased (p = 0.06) in the older cohort. The resting plasma FFA concentration decreased markedly in both gro…

AdultMalecyclingPhysiologyRestendurance exerciseMASSINTRAMYOCELLULAR CERAMIDE ACCUMULATIONH2O2 EMISSIONenergy metabolismHumansCONTROLLED TOURMuscle SkeletalExerciseTriglyceridesAgedaerobic fitnessMORTALITYagingBody WeightENERGY-EXPENDITUREfat oxidationMiddle AgedINSULINPHYSICAL-ACTIVITYMAXIMAL FAT OXIDATIONPhysical EnduranceSKELETAL-MUSCLEmuscle biopsySettore M-EDF/01 - Metodi E Didattiche Delle Attivita' MotorieActa physiologica (Oxford, England)
researchProduct

Long term hemodialysis aggravates lipolytic activity reduction and very low density, low density lipoproteins composition in chronic renal failure pa…

2009

Abstract Background Dyslipidemia, particularly hypertriglyceridemia is common in uremia, and represents an independent risk factor for atherosclerosis. Methods To investigate the effects of hemodialysis (HD) duration on very low density lipoprotein (VLDL) and low density lipoprotein (LDL) compositions and lipopolytic activities, 20 patients on 5 to 7 years hemodialysis were followed-up during 9 years. Blood samples were drawn at T0 (beginning of the study), T1 (3 years after initiating study), T2 (6 years after initiating study) and T3 (9 years after initiating study). T0 was taken as reference. Results Triacylglycerols (TG) values were correlated with HD duration (r = 0.70, P Conclusion De…

AdultMalelcsh:Diseases of the circulatory (Cardiovascular) systemVery low-density lipoproteinmedicine.medical_specialtyTime Factorsmedicine.medical_treatmentLipolysisBlood lipidsLipoproteins VLDLRisk Assessmentchemistry.chemical_compoundRenal DialysisRisk FactorsInternal medicinemedicineHumansInsulinLongitudinal StudiesTriglyceridesDyslipidemiasLipoprotein lipaseApolipoprotein C-IIICholesterolbusiness.industryHypertriglyceridemianutritional and metabolic diseasesLipaseMiddle Agedmedicine.diseaseAtherosclerosisLipoproteins LDLLipoprotein LipaseEndocrinologyCholesterolchemistrylcsh:RC666-701Low-density lipoproteinLinear ModelsKidney Failure Chroniclipids (amino acids peptides and proteins)Apolipoprotein C-IIFemaleHepatic lipaseHemodialysisCardiology and Cardiovascular MedicinebusinessBiomarkersResearch ArticleBMC cardiovascular disorders
researchProduct